{
  "id": "parkinsons-disease",
  "title": "Parkinson's Disease",
  "version": "1.0",
  "icd10": [
    "** G20 (Parkinson's disease)",
    "G20.A1 (Parkinson's disease without dyskinesia",
    "without motor fluctuations)",
    "G20.A2 (Parkinson's disease without dyskinesia",
    "with motor fluctuations)",
    "G20.B1 (Parkinson's disease with dyskinesia",
    "without motor fluctuations)",
    "G20.B2 (Parkinson's disease with dyskinesia",
    "with motor fluctuations)",
    "G20.C (Parkinsonism",
    "unspecified)"
  ],
  "scope": "** Diagnosis confirmation, dopaminergic therapy initiation and optimization, motor fluctuation management, and non-motor symptom treatment. Excludes Parkinson-plus syndromes (MSA, PSP, CBD, DLB - separate protocols).",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC (CPT 85025)",
          "rationale": "Baseline; rule out anemia contributing to fatigue",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "BMP (CPT 80048)",
          "rationale": "Renal function for medication dosing; electrolytes",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Hepatic panel (LFTs) (CPT 80076)",
          "rationale": "Baseline before COMT inhibitors",
          "target": "Normal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "TSH (CPT 84443)",
          "rationale": "Rule out hypothyroidism mimicking bradykinesia",
          "target": "Normal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "rationale": "Deficiency can cause parkinsonism; common in elderly",
          "target": ">300 pg/mL",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Vitamin D, 25-hydroxy (CPT 82306)",
          "rationale": "Deficiency common; associated with falls and disease severity",
          "target": ">30 ng/mL",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "Ceruloplasmin (CPT 82390), serum copper (CPT 82390)",
          "rationale": "Wilson's disease if age <50",
          "target": "Normal",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "24-hour urine copper",
          "rationale": "Wilson's disease confirmation",
          "target": "<100 Î¼g/24hr",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Ferritin (CPT 82728), iron studies (CPT 83540, 83550)",
          "rationale": "Neurodegeneration with brain iron accumulation",
          "target": "Normal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "RPR or VDRL (CPT 86592)",
          "rationale": "Syphilis can cause parkinsonism",
          "target": "Nonreactive",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "HIV testing (CPT 87389)",
          "rationale": "HIV-associated parkinsonism",
          "target": "Negative",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "Genetic testing (LRRK2, GBA, SNCA, PARK2, PINK1, DJ-1)",
          "rationale": "Family history or early-onset (<50 years)",
          "target": "Identifies genetic form",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "CSF biomarkers (alpha-synuclein, tau, amyloid)",
          "rationale": "Research/atypical; synuclein seed amplification assay",
          "target": "Abnormal synuclein aggregation",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Skin biopsy for alpha-synuclein",
          "rationale": "Research; confirms synucleinopathy",
          "target": "Phosphorylated synuclein deposits",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI Brain without contrast (CPT 70551)",
          "timing": "At diagnosis",
          "target": "Normal (rules out structural causes, vascular parkinsonism, NPH)",
          "contraindications": "MRI-incompatible devices",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Extended": [
        {
          "item": "DaTscan (CPT 78830)",
          "timing": "Diagnostic uncertainty; essential tremor vs PD",
          "target": "Reduced dopamine transporter uptake in striatum",
          "contraindications": "Hypersensitivity to iodine",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "MRI Brain with SWI sequence",
          "timing": "Suspected atypical parkinsonism or iron deposition",
          "target": "No \"hot cross bun\" (MSA) or \"hummingbird\" (PSP) signs",
          "contraindications": "MRI contraindications",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cardiac MIBG scan",
          "timing": "Differentiate PD from MSA",
          "target": "Reduced uptake in PD (preserved in MSA)",
          "contraindications": "Recent MI; drugs affecting uptake",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Sleep study (polysomnography) (CPT 95810)",
          "timing": "REM sleep behavior disorder evaluation",
          "target": "Confirms RBD (prodromal marker)",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Autonomic function testing (CPT 95924)",
          "timing": "Dysautonomia assessment",
          "target": "Orthostatic hypotension, abnormal HR variability",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "FDG-PET (CPT 78608)",
          "timing": "Atypical parkinsonism differentiation",
          "target": "Pattern recognition for PD vs PSP vs MSA",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Transcranial ultrasound",
          "timing": "Screening tool",
          "target": "Hyperechogenicity of substantia nigra",
          "contraindications": "Inadequate bone window",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Carbidopa-Levodopa (continue home dose)",
          "route": "PO/NG",
          "indication": "Admitted PD patient; DO NOT HOLD",
          "dosing": {
            "doseOptions": [
              {
                "text": "Home dose, same timing",
                "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
              }
            ],
            "route": "PO",
            "instructions": "Give at EXACT same times as home; crushing allowed; use NG if NPO",
            "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
          },
          "contraindications": "Active psychosis; MAOIs within 14 days",
          "monitoring": "Dyskinesias, confusion",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Carbidopa-Levodopa (NPO protocol)",
          "route": "IV/NG",
          "indication": "Patient NPO >4 hours",
          "dosing": {
            "doseOptions": [
              {
                "text": "Home dose equivalent",
                "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
              }
            ],
            "route": "NG",
            "instructions": "Crush tablets; give via NG at home schedule; consult neurology for IV options if unavailable",
            "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
          },
          "contraindications": "Same as PO",
          "monitoring": "Same as PO",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Apomorphine SC",
          "route": "SC",
          "indication": "Off episode in clinic/ED; NPO patient",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg SC",
                "orderSentence": "Apomorphine SC 2 mg SC SC"
              },
              {
                "text": "3 mg SC",
                "orderSentence": "Apomorphine SC 3 mg SC SC"
              },
              {
                "text": "4 mg SC",
                "orderSentence": "Apomorphine SC 4 mg SC SC"
              },
              {
                "text": "5 mg SC",
                "orderSentence": "Apomorphine SC 5 mg SC SC"
              },
              {
                "text": "6 mg SC",
                "orderSentence": "Apomorphine SC 6 mg SC SC"
              }
            ],
            "route": "SC",
            "instructions": "Test dose 2 mg; titrate by 1 mg to effect; max 6 mg; pretreat with trimethobenzamide",
            "orderSentence": "Apomorphine SC 2 mg SC SC"
          },
          "contraindications": "Concurrent 5-HT3 antagonists (ondansetron); severe hypotension",
          "monitoring": "BP, nausea; may cause severe hypotension",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rotigotine patch",
          "route": "TD",
          "indication": "NPO patient; bridge therapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg/24hr",
                "orderSentence": "Rotigotine patch 2 mg/24hr TD"
              },
              {
                "text": "4 mg/24hr",
                "orderSentence": "Rotigotine patch 4 mg/24hr TD"
              },
              {
                "text": "6 mg/24hr patch",
                "orderSentence": "Rotigotine patch 6 mg/24hr patch TD"
              }
            ],
            "route": "TD",
            "instructions": "Apply patch equivalent to oral dopamine agonist dose; onset 2-3 hours",
            "orderSentence": "Rotigotine patch 2 mg/24hr TD"
          },
          "contraindications": "Sulfite allergy (adhesive)",
          "monitoring": "Application site reactions",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Trimethobenzamide",
          "route": "IM/PO",
          "indication": "Pretreat before apomorphine to prevent nausea",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg IM/PO",
                "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
              }
            ],
            "route": "IM/PO",
            "instructions": "300 mg TID starting 3 days before apomorphine initiation",
            "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
          },
          "contraindications": "Hypersensitivity",
          "monitoring": "Drowsiness",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "Carbidopa-Levodopa IR (Sinemet)",
          "route": "PO",
          "indication": "Motor symptoms; first-line dopaminergic therapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "25/100 TID",
                "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
              },
              {
                "text": "25/250 TID",
                "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/250 TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25/100 TID; titrate by 1 tablet q1-2wk; typical target 25/100-25/250 TID",
            "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
          },
          "contraindications": "Active psychosis; MAOIs within 14 days",
          "monitoring": "Dyskinesias, nausea, orthostatic hypotension",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carbidopa-Levodopa CR (Sinemet CR)",
          "route": "PO",
          "indication": "Nocturnal symptoms; wearing off",
          "dosing": {
            "doseOptions": [
              {
                "text": "25/100 CR qHS",
                "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
              },
              {
                "text": "50/200 CR BID",
                "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 50/200 CR BID PO"
              }
            ],
            "route": "PO",
            "instructions": "25/100 to 50/200 CR at bedtime or BID; 70% bioavailability vs IR",
            "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
          },
          "contraindications": "Same as IR",
          "monitoring": "Same as IR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carbidopa-Levodopa ER (Rytary)",
          "route": "PO",
          "indication": "Motor fluctuations; extend levodopa effect",
          "dosing": {
            "doseOptions": [
              {
                "text": "23.75/95 TID",
                "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
              },
              {
                "text": "36.25/145 TID",
                "orderSentence": "Carbidopa-Levodopa ER (Rytary) 36.25/145 TID PO"
              },
              {
                "text": "48.75/195 TID",
                "orderSentence": "Carbidopa-Levodopa ER (Rytary) 48.75/195 TID PO"
              },
              {
                "text": "61.25/245 TID",
                "orderSentence": "Carbidopa-Levodopa ER (Rytary) 61.25/245 TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Convert from IR using manufacturer table; typically TID dosing",
            "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
          },
          "contraindications": "Same as IR",
          "monitoring": "Same as IR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pramipexole",
          "route": "PO",
          "indication": "Adjunct to levodopa; monotherapy in early PD; tremor",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.125 mg TID",
                "orderSentence": "Pramipexole 0.125 mg TID PO"
              },
              {
                "text": "0.25 mg TID",
                "orderSentence": "Pramipexole 0.25 mg TID PO"
              },
              {
                "text": "0.5 mg TID",
                "orderSentence": "Pramipexole 0.5 mg TID PO"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Pramipexole 1 mg TID PO"
              },
              {
                "text": "1.5 mg TID",
                "orderSentence": "Pramipexole 1.5 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.125 mg TID; titrate by 0.125-0.25 mg TID q5-7 days; max 1.5 mg TID",
            "orderSentence": "Pramipexole 0.125 mg TID PO"
          },
          "contraindications": "Impulse control history",
          "monitoring": "Impulse control disorders, somnolence, leg edema",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ropinirole",
          "route": "PO",
          "indication": "Adjunct or monotherapy; similar to pramipexole",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25 mg TID",
                "orderSentence": "Ropinirole 0.25 mg TID PO"
              },
              {
                "text": "0.5 mg TID",
                "orderSentence": "Ropinirole 0.5 mg TID PO"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Ropinirole 1 mg TID PO"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Ropinirole 2 mg TID PO"
              },
              {
                "text": "3 mg TID",
                "orderSentence": "Ropinirole 3 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.25 mg TID; titrate weekly; max 8 mg TID",
            "orderSentence": "Ropinirole 0.25 mg TID PO"
          },
          "contraindications": "Same as pramipexole",
          "monitoring": "Same as pramipexole",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ropinirole XL",
          "route": "PO",
          "indication": "Extended-release option for adherence",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg daily",
                "orderSentence": "Ropinirole XL 2 mg daily PO"
              },
              {
                "text": "4 mg daily",
                "orderSentence": "Ropinirole XL 4 mg daily PO"
              },
              {
                "text": "6 mg daily",
                "orderSentence": "Ropinirole XL 6 mg daily PO"
              },
              {
                "text": "8 mg daily",
                "orderSentence": "Ropinirole XL 8 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2 mg daily; titrate by 2 mg q1-2wk; max 24 mg daily",
            "orderSentence": "Ropinirole XL 2 mg daily PO"
          },
          "contraindications": "Same as IR",
          "monitoring": "Same as IR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Selegiline",
          "route": "PO",
          "indication": "MAO-B inhibitor; adjunct; mild neuroprotection theory",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg BID",
                "orderSentence": "Selegiline 5 mg BID PO"
              }
            ],
            "route": "PO",
            "instructions": "5 mg at breakfast and lunch (avoid evening due to insomnia); max 10 mg/day",
            "orderSentence": "Selegiline 5 mg BID PO"
          },
          "contraindications": "MAOIs; meperidine; TCAs (caution)",
          "monitoring": "Insomnia, hypertensive crisis with tyramine (rare at this dose)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rasagiline",
          "route": "PO",
          "indication": "MAO-B inhibitor; once daily; adjunct or monotherapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg daily",
                "orderSentence": "Rasagiline 0.5 mg daily PO"
              },
              {
                "text": "1 mg daily",
                "orderSentence": "Rasagiline 1 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.5-1 mg daily; max 1 mg daily",
            "orderSentence": "Rasagiline 0.5 mg daily PO"
          },
          "contraindications": "Same as selegiline",
          "monitoring": "Hypertensive crisis (rare); serotonin syndrome with other serotonergics",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Safinamide",
          "route": "PO",
          "indication": "MAO-B inhibitor with additional mechanisms; adjunct in fluctuations",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg daily",
                "orderSentence": "Safinamide 50 mg daily PO"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Safinamide 100 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 50 mg daily; may increase to 100 mg daily after 2 weeks",
            "orderSentence": "Safinamide 50 mg daily PO"
          },
          "contraindications": "Severe hepatic impairment; MAOIs; opioids",
          "monitoring": "Same as rasagiline; may improve dyskinesia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Entacapone",
          "route": "PO",
          "indication": "COMT inhibitor; extends levodopa effect; wearing off",
          "dosing": {
            "doseOptions": [
              {
                "text": "200 mg with each levodopa dose",
                "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
              }
            ],
            "route": "PO",
            "instructions": "200 mg with each levodopa dose; max 8 doses (1600 mg)/day",
            "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
          },
          "contraindications": "Hepatic impairment; concurrent MAOIs",
          "monitoring": "Diarrhea, orange urine, dyskinesias",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Opicapone",
          "route": "PO",
          "indication": "COMT inhibitor; once daily alternative to entacapone",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg qHS",
                "orderSentence": "Opicapone 50 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "50 mg once daily at bedtime; take 1 hour before or after levodopa",
            "orderSentence": "Opicapone 50 mg qHS PO"
          },
          "contraindications": "Pheochromocytoma; paraganglioma",
          "monitoring": "Dyskinesias, constipation, dry mouth",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amantadine",
          "route": "PO",
          "indication": "Dyskinesia reduction; mild motor benefit",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg BID",
                "orderSentence": "Amantadine 100 mg BID PO"
              },
              {
                "text": "100 mg TID",
                "orderSentence": "Amantadine 100 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg daily; titrate to 100 mg BID-TID; max 400 mg/day; dose-reduce in renal impairment",
            "orderSentence": "Amantadine 100 mg BID PO"
          },
          "contraindications": "End-stage renal disease; seizure history",
          "monitoring": "Livedo reticularis, ankle edema, confusion, hallucinations",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amantadine ER (Gocovri)",
          "route": "PO",
          "indication": "Dyskinesia; extended-release taken at bedtime",
          "dosing": {
            "doseOptions": [
              {
                "text": "137 mg qHS",
                "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
              },
              {
                "text": "274 mg qHS",
                "orderSentence": "Amantadine ER (Gocovri) 274 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 137 mg qHS; increase to 274 mg qHS after 1 week",
            "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
          },
          "contraindications": "Same as IR",
          "monitoring": "Same as IR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Trihexyphenidyl",
          "route": "PO",
          "indication": "Tremor-dominant PD; younger patients",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg TID",
                "orderSentence": "Trihexyphenidyl 1 mg TID PO"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Trihexyphenidyl 2 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 1 mg TID; titrate by 2 mg/day q3-5 days; max 15 mg/day",
            "orderSentence": "Trihexyphenidyl 1 mg TID PO"
          },
          "contraindications": "Glaucoma; urinary retention; dementia; age >70",
          "monitoring": "Cognitive impairment, dry mouth, constipation, urinary retention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Benztropine",
          "route": "PO",
          "indication": "Alternative anticholinergic for tremor",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg BID",
                "orderSentence": "Benztropine 0.5 mg BID PO"
              },
              {
                "text": "1 mg BID",
                "orderSentence": "Benztropine 1 mg BID PO"
              },
              {
                "text": "2 mg BID",
                "orderSentence": "Benztropine 2 mg BID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.5 mg BID; titrate slowly; max 6 mg/day",
            "orderSentence": "Benztropine 0.5 mg BID PO"
          },
          "contraindications": "Same as trihexyphenidyl",
          "monitoring": "Same as trihexyphenidyl",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Istradefylline",
          "route": "PO",
          "indication": "Adenosine A2A antagonist; adjunct for OFF time",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg daily",
                "orderSentence": "Istradefylline 20 mg daily PO"
              },
              {
                "text": "40 mg daily",
                "orderSentence": "Istradefylline 40 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 20 mg daily; may increase to 40 mg daily",
            "orderSentence": "Istradefylline 20 mg daily PO"
          },
          "contraindications": "Strong CYP3A4 inducers",
          "monitoring": "Dyskinesias, dizziness, constipation, hallucinations",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Non-Motor Symptom Treatments": [
        {
          "item": "Pimavanserin (Nuplazid)",
          "route": "PO",
          "indication": "Parkinson's disease psychosis (hallucinations, delusions)",
          "dosing": {
            "doseOptions": [
              {
                "text": "34 mg daily",
                "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration needed",
            "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
          },
          "contraindications": "Severe hepatic impairment; QT prolongation",
          "monitoring": "QTc, efficacy assessment at 6 weeks",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Quetiapine",
          "route": "PO",
          "indication": "Psychosis; alternative if pimavanserin unavailable",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg qHS",
                "orderSentence": "Quetiapine 12.5 mg qHS PO"
              },
              {
                "text": "25 mg qHS",
                "orderSentence": "Quetiapine 25 mg qHS PO"
              },
              {
                "text": "50 mg qHS",
                "orderSentence": "Quetiapine 50 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 12.5-25 mg qHS; titrate slowly by 12.5-25 mg q3-7d; typical max 150 mg/day",
            "orderSentence": "Quetiapine 12.5 mg qHS PO"
          },
          "contraindications": "Dementia with Lewy bodies (black box)",
          "monitoring": "Sedation, metabolic effects, QTc",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clozapine",
          "route": "PO",
          "indication": "Refractory psychosis; best evidence but monitoring required",
          "dosing": {
            "doseOptions": [
              {
                "text": "6.25 mg qHS",
                "orderSentence": "Clozapine 6.25 mg qHS PO"
              },
              {
                "text": "12.5 mg qHS",
                "orderSentence": "Clozapine 12.5 mg qHS PO"
              },
              {
                "text": "25 mg qHS",
                "orderSentence": "Clozapine 25 mg qHS PO"
              },
              {
                "text": "50 mg qHS",
                "orderSentence": "Clozapine 50 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 6.25-12.5 mg qHS; titrate by 12.5 mg q1-2wk; max 50-100 mg/day in PD",
            "orderSentence": "Clozapine 6.25 mg qHS PO"
          },
          "contraindications": "REMS enrollment required",
          "monitoring": "ANC weekly x 6 mo, then q2wk x 6 mo, then monthly; agranulocytosis risk",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rivastigmine (Exelon)",
          "route": "PO/Patch",
          "indication": "Parkinson's disease dementia",
          "dosing": {
            "doseOptions": [
              {
                "text": "1.5 mg BID",
                "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
              },
              {
                "text": "3 mg BID",
                "orderSentence": "Rivastigmine (Exelon) 3 mg BID PO/Patch"
              },
              {
                "text": "4.5 mg BID",
                "orderSentence": "Rivastigmine (Exelon) 4.5 mg BID PO/Patch"
              },
              {
                "text": "6 mg BID",
                "orderSentence": "Rivastigmine (Exelon) 6 mg BID PO/Patch"
              },
              {
                "text": "9.5 mg/24hr patch",
                "orderSentence": "Rivastigmine (Exelon) 9.5 mg/24hr patch PO/Patch"
              },
              {
                "text": "13.3 mg/24hr patch",
                "orderSentence": "Rivastigmine (Exelon) 13.3 mg/24hr patch PO/Patch"
              }
            ],
            "route": "PO/Patch",
            "instructions": "Start 1.5 mg BID or 4.6 mg/24hr patch; titrate monthly; max 6 mg BID or 13.3 mg/24hr",
            "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
          },
          "contraindications": "Severe hepatic impairment",
          "monitoring": "Nausea, weight loss, tremor worsening",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Donepezil",
          "route": "PO",
          "indication": "Parkinson's disease dementia; once daily option",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg qHS",
                "orderSentence": "Donepezil 5 mg qHS PO"
              },
              {
                "text": "10 mg qHS",
                "orderSentence": "Donepezil 10 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg qHS; increase to 10 mg after 4-6 weeks",
            "orderSentence": "Donepezil 5 mg qHS PO"
          },
          "contraindications": "GI bleeding; sick sinus syndrome",
          "monitoring": "Nausea, bradycardia, vivid dreams",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Memantine",
          "route": "PO",
          "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg daily",
                "orderSentence": "Memantine 5 mg daily PO"
              },
              {
                "text": "10 mg BID",
                "orderSentence": "Memantine 10 mg BID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
            "orderSentence": "Memantine 5 mg daily PO"
          },
          "contraindications": "Severe renal impairment (dose adjust)",
          "monitoring": "Confusion, constipation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Midodrine",
          "route": "PO",
          "indication": "Orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg TID",
                "orderSentence": "Midodrine 2.5 mg TID PO"
              },
              {
                "text": "5 mg TID",
                "orderSentence": "Midodrine 5 mg TID PO"
              },
              {
                "text": "10 mg TID",
                "orderSentence": "Midodrine 10 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2.5 mg TID (before arising, before lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
            "orderSentence": "Midodrine 2.5 mg TID PO"
          },
          "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
          "monitoring": "Supine BP (must avoid lying flat for 4 hours after dose)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Droxidopa (Northera)",
          "route": "PO",
          "indication": "Neurogenic orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg TID",
                "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
              },
              {
                "text": "200 mg TID",
                "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
              },
              {
                "text": "300 mg TID",
                "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
              },
              {
                "text": "600 mg TID",
                "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
            "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
          },
          "contraindications": "Supine hypertension",
          "monitoring": "Supine BP, headache",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fludrocortisone",
          "route": "PO",
          "indication": "Orthostatic hypotension adjunct",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.1 mg daily",
                "orderSentence": "Fludrocortisone 0.1 mg daily PO"
              },
              {
                "text": "0.2 mg daily",
                "orderSentence": "Fludrocortisone 0.2 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
            "orderSentence": "Fludrocortisone 0.1 mg daily PO"
          },
          "contraindications": "CHF; renal failure; severe hypertension",
          "monitoring": "K+, edema, supine BP",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Sertraline",
          "route": "PO",
          "indication": "Depression in PD",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg daily",
                "orderSentence": "Sertraline 25 mg daily PO"
              },
              {
                "text": "50 mg daily",
                "orderSentence": "Sertraline 50 mg daily PO"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Sertraline 100 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg daily",
            "orderSentence": "Sertraline 25 mg daily PO"
          },
          "contraindications": "MAOIs within 14 days",
          "monitoring": "Serotonin syndrome (caution with MAO-B inhibitors)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Venlafaxine XR",
          "route": "PO",
          "indication": "Depression; anxiety in PD",
          "dosing": {
            "doseOptions": [
              {
                "text": "37.5 mg daily",
                "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
              },
              {
                "text": "75 mg daily",
                "orderSentence": "Venlafaxine XR 75 mg daily PO"
              },
              {
                "text": "150 mg daily",
                "orderSentence": "Venlafaxine XR 150 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg daily",
            "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
          },
          "contraindications": "Same as sertraline",
          "monitoring": "BP at higher doses",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Polyethylene glycol (MiraLAX)",
          "route": "PO",
          "indication": "Constipation (ubiquitous in PD)",
          "dosing": {
            "doseOptions": [
              {
                "text": "17 g daily",
                "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
              },
              {
                "text": "17 g BID",
                "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
              }
            ],
            "route": "PO",
            "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
            "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
          },
          "contraindications": "Bowel obstruction",
          "monitoring": "Diarrhea if excessive",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Senna + docusate",
          "route": "PO",
          "indication": "Constipation stimulant",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 tablets qHS",
                "orderSentence": "Senna + docusate 2 tablets qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "2 tablets qHS; may increase to 4 tablets",
            "orderSentence": "Senna + docusate 2 tablets qHS PO"
          },
          "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
          "monitoring": "Electrolytes with chronic use",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clonazepam",
          "route": "PO",
          "indication": "REM sleep behavior disorder",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25 mg qHS",
                "orderSentence": "Clonazepam 0.25 mg qHS PO"
              },
              {
                "text": "0.5 mg qHS",
                "orderSentence": "Clonazepam 0.5 mg qHS PO"
              },
              {
                "text": "1 mg qHS",
                "orderSentence": "Clonazepam 1 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.25-0.5 mg qHS; titrate to effect; typical 0.5-1 mg",
            "orderSentence": "Clonazepam 0.25 mg qHS PO"
          },
          "contraindications": "Severe sleep apnea; respiratory compromise",
          "monitoring": "Sedation, falls, cognitive effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Melatonin",
          "route": "PO",
          "indication": "REM sleep behavior disorder; sleep disturbance",
          "dosing": {
            "doseOptions": [
              {
                "text": "3 mg qHS",
                "orderSentence": "Melatonin 3 mg qHS PO"
              },
              {
                "text": "6 mg qHS",
                "orderSentence": "Melatonin 6 mg qHS PO"
              },
              {
                "text": "9 mg qHS",
                "orderSentence": "Melatonin 9 mg qHS PO"
              },
              {
                "text": "12 mg qHS",
                "orderSentence": "Melatonin 12 mg qHS PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 3-6 mg qHS; may increase to 12 mg",
            "orderSentence": "Melatonin 3 mg qHS PO"
          },
          "contraindications": "None",
          "monitoring": "Generally well-tolerated",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Glycopyrrolate",
          "route": "PO",
          "indication": "Sialorrhea (drooling)",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg TID",
                "orderSentence": "Glycopyrrolate 1 mg TID PO"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Glycopyrrolate 2 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 1 mg TID; titrate to effect; max 2 mg TID",
            "orderSentence": "Glycopyrrolate 1 mg TID PO"
          },
          "contraindications": "Glaucoma; urinary retention; GI obstruction",
          "monitoring": "Dry mouth, constipation, urinary retention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "OnabotulinumtoxinA (salivary glands)",
          "route": "IM",
          "indication": "Sialorrhea refractory to oral therapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 units total",
                "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
              }
            ],
            "route": "IM",
            "instructions": "30-50 units per parotid, 10-20 units per submandibular; repeat q3-4 months",
            "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
          },
          "contraindications": "Infection at site",
          "monitoring": "Dysphagia (rare), dry mouth",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Advanced Therapies": [
        {
          "item": "Deep brain stimulation (DBS)",
          "route": "Surgical",
          "indication": "Motor fluctuations or tremor refractory to optimal medication",
          "dosing": {
            "doseOptions": [
              {
                "text": "STN or GPi stimulation",
                "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Unilateral or bilateral; programming done over weeks post-op",
            "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
          },
          "pretreatment": "Neuropsych testing, MRI, off-medication evaluation",
          "contraindications": "Dementia; active psychiatric disease; medical comorbidities",
          "monitoring": "Programming optimization; battery checks",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Levodopa-carbidopa intestinal gel (Duopa)",
          "route": "Enteral",
          "indication": "Severe motor fluctuations; 4+ hours OFF/day",
          "dosing": {
            "doseOptions": [
              {
                "text": "Continuous infusion",
                "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
              }
            ],
            "route": "Enteral",
            "instructions": "Via PEG-J; 16-hour infusion; morning bolus + continuous rate + extra doses",
            "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
          },
          "pretreatment": "GI tract accessible",
          "contraindications": "GI disease preventing PEG-J; coagulopathy",
          "monitoring": "Tube site, infections, GI complications",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Apomorphine continuous infusion",
          "route": "SC",
          "indication": "Severe motor fluctuations; not DBS candidate",
          "dosing": {
            "doseOptions": [
              {
                "text": "3-8 mg/hr continuous",
                "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
              }
            ],
            "route": "SC",
            "instructions": "Via subcutaneous pump; typical 3-8 mg/hr during waking hours",
            "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
          },
          "pretreatment": "Caregiver training",
          "contraindications": "Same as SC apomorphine",
          "monitoring": "Same as SC apomorphine",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Movement disorders specialist for diagnosis confirmation and advanced therapy evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for gait training, balance exercises, and LSVT BIG program",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for ADL adaptation and fine motor strategies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Speech therapy (LSVT LOUD) for hypophonia and swallowing evaluation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neuropsychology for cognitive assessment and DBS candidacy evaluation",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Psychiatry for depression, anxiety, impulse control disorders, or psychosis management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Palliative care for advanced disease symptom management and goals of care",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for caregiver support, community resources, and disability planning",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Urology for urinary symptoms not responsive to first-line treatment",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gastroenterology for severe constipation or Duopa tube placement",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "CRITICAL: Do not skip or delay levodopa doses as this can cause severe OFF episodes and immobility",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Take levodopa 30-60 minutes before meals for better absorption (protein competes with levodopa transport)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Inform all healthcare providers about PD medications to avoid drug interactions (especially antipsychotics, antiemetics)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report any new impulsive behaviors (gambling, shopping, hypersexuality) which may indicate impulse control disorder from dopamine agonists",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report hallucinations early as these can be managed with medication adjustment",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Engage in regular exercise which may slow disease progression and improves mobility",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Regular aerobic exercise (30-60 min, 3-5x/week) improves motor function and may be neuroprotective",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Tai chi or dance-based exercise programs improve balance and reduce falls",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "High-fiber diet and adequate hydration to prevent constipation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid medications that worsen parkinsonism (metoclopramide, prochlorperazine, haloperidol, risperidone)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Mediterranean diet may have protective benefits based on observational studies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Coffee consumption associated with reduced PD risk; continued moderate use reasonable",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Drug-induced parkinsonism",
      "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no levodopa response",
      "tests": "DaTscan normal; history of causative medication"
    },
    {
      "diagnosis": "Vascular parkinsonism",
      "features": "Stepwise progression; lower body predominant; vascular risk factors; pyramidal signs",
      "tests": "MRI with subcortical/basal ganglia infarcts"
    },
    {
      "diagnosis": "Progressive supranuclear palsy (PSP)",
      "features": "Early falls; vertical gaze palsy; axial rigidity > limb; poor levodopa response",
      "tests": "MRI \"hummingbird sign\"; clinical criteria"
    },
    {
      "diagnosis": "Multiple system atrophy (MSA)",
      "features": "Severe dysautonomia; cerebellar signs; stridor; poor levodopa response",
      "tests": "MRI \"hot cross bun\" sign; MIBG preserved"
    },
    {
      "diagnosis": "Corticobasal degeneration (CBD)",
      "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
      "tests": "MRI asymmetric cortical atrophy"
    },
    {
      "diagnosis": "Dementia with Lewy bodies (DLB)",
      "features": "Dementia before or within 1 year of motor symptoms; fluctuating cognition; visual hallucinations",
      "tests": "Clinical criteria; DaTscan may be abnormal"
    },
    {
      "diagnosis": "Essential tremor",
      "features": "Action tremor > rest tremor; improves with alcohol; family history; no bradykinesia",
      "tests": "DaTscan normal; clinical criteria"
    },
    {
      "diagnosis": "Normal pressure hydrocephalus",
      "features": "Gait apraxia (\"magnetic gait\"); urinary incontinence; dementia",
      "tests": "MRI ventricular enlargement; LP with gait improvement"
    }
  ],
  "evidence": [
    {
      "recommendation": "Levodopa most effective symptomatic treatment",
      "evidenceLevel": "Class I, Level A",
      "source": "[Fahn et al. NEJM 2004 (ELLDOPA)](https://pubmed.ncbi.nlm.nih.gov/15590952/)"
    },
    {
      "recommendation": "MAO-B inhibitors provide mild motor benefit",
      "evidenceLevel": "Class I, Level A",
      "source": "[Rascol et al. NEJM 2005 (rasagiline)](https://pubmed.ncbi.nlm.nih.gov/16217047/)"
    },
    {
      "recommendation": "Pimavanserin for PD psychosis",
      "evidenceLevel": "Class I, Level A",
      "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24183563/)"
    },
    {
      "recommendation": "DBS improves motor fluctuations",
      "evidenceLevel": "Class I, Level A",
      "source": "[Weaver et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/19126811/)"
    },
    {
      "recommendation": "Rivastigmine for PD dementia",
      "evidenceLevel": "Class I, Level A",
      "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
    },
    {
      "recommendation": "Exercise improves motor function",
      "evidenceLevel": "Class II, Level B",
      "source": "[Schenkman et al. JAMA Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29228079/)"
    },
    {
      "recommendation": "LSVT LOUD improves speech",
      "evidenceLevel": "Class I, Level B",
      "source": "[Ramig et al. JSLHR 2001](https://pubmed.ncbi.nlm.nih.gov/11324652/)"
    },
    {
      "recommendation": "Clonazepam and melatonin for RBD",
      "evidenceLevel": "Class II, Level B",
      "source": "[Aurora et al. AASM 2010](https://pubmed.ncbi.nlm.nih.gov/21061864/)"
    },
    {
      "recommendation": "Amantadine reduces dyskinesia",
      "evidenceLevel": "Class I, Level A",
      "source": "[Ory-Magne et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/25340202/)"
    },
    {
      "recommendation": "Duopa for motor fluctuations",
      "evidenceLevel": "Class I, Level A",
      "source": "[Olanow et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24361112/)"
    }
  ],
  "monitoring": [
    {
      "item": "Motor function (UPDRS-III or MDS-UPDRS)",
      "frequency": "Every visit",
      "action": "Adjust medications if worsening",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ON/OFF time diary",
      "frequency": "Daily for 1 week before visits",
      "action": "Add adjunct therapy; consider advanced options",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Dyskinesia severity",
      "frequency": "Each visit",
      "action": "Reduce levodopa; add amantadine; adjust timing",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Orthostatic blood pressure",
      "frequency": "Each visit",
      "action": "Add midodrine or droxidopa",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Cognition (MoCA)",
      "frequency": "Annually, more often if concerns",
      "action": "Add cholinesterase inhibitor; adjust anticholinergics",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Mood (GDS, PHQ-9)",
      "frequency": "Annually",
      "action": "Add antidepressant; psychiatry referral",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Impulse control screen (QUIP)",
      "frequency": "Each visit if on dopamine agonist",
      "action": "Reduce or discontinue dopamine agonist",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Falls frequency",
      "frequency": "Each visit",
      "action": "PT referral; medication review; home safety evaluation",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Swallowing function",
      "frequency": "Annually or if symptoms",
      "action": "Speech therapy; modify diet",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ANC (if on clozapine)",
      "frequency": "Per REMS protocol",
      "action": "Hold clozapine if ANC <1000; discontinue if <500",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Stable motor status; able to take PO; adequate caregiver support; follow-up arranged"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Unable to take PO medications >24 hours; severe OFF episode; aspiration pneumonia; acute infection"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Neuroleptic malignant syndrome; severe rigidity with rhabdomyolysis; respiratory compromise"
    },
    {
      "disposition": "Outpatient follow-up",
      "criteria": "Every 3-6 months for stable patients; more frequently during medication adjustments"
    }
  ]
}